Intellectual Property India Publishes Patent Application for 'Antisense Oligomers For Treatment Of Non-Sense Mediated Rna Decay Based Conditions And Diseases' Filed by Stoke Therapeutics, Inc.

MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517047030 A) filed by Stoke Therapeutics, Inc., Bedford, U.S.A., on May 15, for 'antisense oligomers for treatment of non-sense mediated rna decay based conditions and diseases.'

Inventor(s) include Aznarez, Isabel; Kach, Jacob; Ramachandran, Pavitra; and Saiz, Ana Corrionero.

The application for the patent was published on Aug. 22, under issue no. 34/2025.

According to the abstract released by the Intellectual Property India: "Alternative splicing events in genes can lead to non-productive mRNA transcripts which in turn can lead to aberrant or reduced protein expression, and therapeutic agents which can target the alternative splicing events in ...